Tristem Medika Indonesia
PT. Tristem Medika Indonesia is an emerging biotechnology company focused on the development and manufacture of safe, affordable, and innovative cell and protein-based therapeutics to treat a range of unmet medical needs. Currently, Tristem focused on the development of mesenchymal stem cell with enhanced characteristics and insignificant or null HLA-DR antigens.
Team
Tristem has a team of experts in the development and manufacture to advance our technology.
Facility
Tristem manufacturing facility follows strict quality control requirements.
Publication
Tristem always gaze for innovation in cell and protein therapy.
Inventing Healthier Future.
Established in 2019, Tristem as a biotechnology company with state-of-the-art technology, Tristem commits to create breakthrough and innovation to answer underserved medical condition.